|8.19||+0.28 / +3.54%|
As of 3:59pm ET
|8.22||+0.03 / +0.37%|
The 4 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 19.00 and a low estimate of 5.75. The median estimate represents a +40.42% increase from the last price of 8.19.
The current consensus among 4 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.